Switch to:
Pfizer Inc (NYSE:PFE)
Research and Development
$7,549 Mil (TTM As of Jun. 2016)

This is the expense the company spent on research and development. Pfizer Inc's research and development for the three months ended in Jun. 2016 was $1,748 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2016 was $7,549 Mil.


Definition

This is the expense the company spent on research and development.

Pfizer Inc Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 was 1722 (Sep. 2015 ) + 2348 (Dec. 2015 ) + 1731 (Mar. 2016 ) + 1748 (Jun. 2016 ) = $7,549 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Pfizer Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Research & Development 7,5998,0898,5787,8459,4838,6817,4826,6788,3937,690

Pfizer Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
Research & Development 1,6231,7591,8023,2091,8851,7341,7222,3481,7311,748
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK